Your browser doesn't support javascript.
loading
Bone marrow-derived mesenchymal stem cells inhibit NK cell function via Tim-3/galectin-9 in multiple myeloma patients.
Liu, Zhao-Yun; Meng, Nan-Hao; Cao, Pan-Pan; Jia, Yue; Wang, Hao; Zhang, Yun-He; Liu, Hui; Fu, Rong.
Affiliation
  • Liu ZY; Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China.
  • Meng NH; Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China.
  • Cao PP; Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China.
  • Jia Y; Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China.
  • Wang H; Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China.
  • Zhang YH; Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China.
  • Liu H; Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China.
  • Fu R; Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China.
Clin Transl Med ; 13(3): e1224, 2023 03.
Article in En | MEDLINE | ID: mdl-36938997

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mesenchymal Stem Cells / Multiple Myeloma Limits: Humans Language: En Journal: Clin Transl Med Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mesenchymal Stem Cells / Multiple Myeloma Limits: Humans Language: En Journal: Clin Transl Med Year: 2023 Type: Article